Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On September 8, 2022, Artemis Therapeutics, Inc., or the Company, filed a Certificate of Amendment to the Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware, or the Certificate of Amendment, pursuant to which the Company increased the number of authorized shares of common stock from 51,000,000 to 150,000,000, or the Authorized Capital Change. The Authorized Capital Change took effect on September 8, 2022.

The Board of Directors approved the Authorized Capital Change on July 25, 2022 and the holders of a majority of the Company's outstanding common stock approved the Authorized Capital Change on July 27, 2022.

The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 hereto and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits

Exhibit No.   Description
  3.1           Certificate of Amendment, dated September 8, 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses